LON:PYC Physiomics (PYC) Share Price, News & Analysis → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Free PYC Stock Alerts GBX 1.30 -0.20 (-13.33%) (As of 05/3/2024 ET) Add Compare Share Share Today's Range 1.03▼ 1.3650-Day Range 1.10▼ 1.5752-Week Range 0.90▼ 3.29Volume2.48 million shsAverage Volume655,609 shsMarket Capitalization£1.76 millionP/E RatioN/ADividend Yield6.20%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines Get Physiomics alerts: Email Address Ad Stansberry ResearchGold ManiaFormer Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).See his free reveal right here. About Physiomics Stock (LON:PYC)Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.Read More PYC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PYC Stock News HeadlinesMay 3, 2024 | americanbankingnews.comPhysiomics (LON:PYC) Shares Down 10.1% February 6, 2024 | lse.co.ukSMALL-CAP WINNERS & LOSERS: CMC Markets up amid cost savings actionMay 3, 2024 | Colonial Metals (Ad)The asset beating inflation by 4x"Trump Loophole" Beats Inflation? Inflation has been out of control for years. Forcing you to work longer and harder for more money that is worth less. By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties.January 22, 2024 | lse.co.ukPhysiomics appoints COO Sargent as new CEO; completes restructuringJanuary 13, 2024 | morningstar.comPYC Therapeutics Ltd PYCNovember 15, 2023 | finance.yahoo.comSome Shareholders May Object To A Pay Rise For Physiomics Plc's (LON:PYC) CEO This YearNovember 10, 2023 | lse.co.ukPhysiomics gets UK government grant for oncology dosing tool projectSeptember 30, 2023 | finance.yahoo.comPhysiomics Full Year 2023 Earnings: Revenues DisappointMay 3, 2024 | Colonial Metals (Ad)The asset beating inflation by 4x"Trump Loophole" Beats Inflation? Inflation has been out of control for years. Forcing you to work longer and harder for more money that is worth less. By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties.September 4, 2023 | marketwatch.comPhysiomics Names Peter Sargent as New COOAugust 31, 2023 | marketwatch.comPhysiomics Wins Further Contract With Merck KGaAJune 27, 2023 | marketwatch.comPhysiomics Raises GBP335,000 to Fund Growth OpportunitiesMay 31, 2023 | lse.co.ukPhysiomics to work with University of Sheffield on cancer researchMay 23, 2023 | marketwatch.comPhysiomics Shares Fall After FY 2023 Income Guidance CutApril 4, 2023 | marketwatch.comPhysiomics Shares Tumble After on Expectation of FY 2023 Income SlipMarch 7, 2023 | marketwatch.comPhysiomics 1H Pretax Loss Widened on Staff CostsOctober 12, 2022 | marketwatch.comPhysiomics Gets Contract With Cancer Research UKSeptember 8, 2022 | reuters.comPYSM.L - Physiomics Plc | Stock Price & Latest News | ReutersApril 8, 2022 | marketwatch.comPhysiomics Awarded Contract by French Pharmaceutical Company ServierDecember 13, 2021 | marketwatch.comPhysiomics Signs New Agreements With Merck KGaA for GBP300,000See More Headlines Receive PYC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Physiomics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings9/30/2020Today5/03/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:PYC CUSIPN/A CIKN/A Webwww.physiomics-plc.com Phone+44-1865-784980FaxN/AEmployees10Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net Margins-70.32% Pretax MarginN/A Return on Equity-62.94% Return on Assets-37.22% Debt Debt-to-Equity RatioN/A Current Ratio6.47 Quick Ratio6.48 Sales & Book Value Annual Sales£900,707.00 Price / Sales1.85 Cash FlowGBX 0.29 per share Price / Cash Flow4.21 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares135,470,000Free FloatN/AMarket Cap£1.67 million OptionableNot Optionable Beta1.78 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesDr. Christophe D. Chassagnole Ph.D. (Age 54)Chief Scientific Officer & Executive Director Comp: $87.48kDr. Peter Joseph Sargent (Age 46)CEO, COO & Director Prof. David FellCo-Founder & Member of Scientific Advisory BoardMr. Anthony Louis Clayden ACA (Age 56)BSc (Hons), MSI, Head of Finance & Company Secretary Ms. Hayley CloseHead of Business DevelopmentDr. Venkata PutchaHead of BiostatisticsDr. Mark Middleton M.D.Ph.D., Consultant & Member of Scientific Advisory BoardDr. Robert Jackson Ph.D. (Age 80)Consultant & Member of Scientific Advisory Board More ExecutivesKey CompetitorsEvgen PharmaLON:EVGReNeuron GroupLON:RENESalvaRx GroupLON:SALVNuformixLON:NFXFusion AntibodiesLON:FABView All Competitors PYC Stock Analysis - Frequently Asked Questions How have PYC shares performed in 2024? Physiomics' stock was trading at GBX 1.60 at the beginning of the year. Since then, PYC shares have decreased by 18.8% and is now trading at GBX 1.30. View the best growth stocks for 2024 here. How were Physiomics' earnings last quarter? Physiomics Plc (LON:PYC) issued its quarterly earnings data on Wednesday, September, 30th. The company reported ($0.09) earnings per share (EPS) for the quarter. Physiomics had a negative net margin of 70.32% and a negative trailing twelve-month return on equity of 62.94%. What other stocks do shareholders of Physiomics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Physiomics investors own include Andalas Energy and Power (ADL), Uranium Energy (UEC), Tavistock Investments (TAVI), Sorrento Therapeutics (SRNE), Photonstar Led Group (PSL), IGas Energy (IGAS) and Hertz Global (HTZ). How do I buy shares of Physiomics? Shares of PYC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:PYC) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldUrgent Nvidia WarningAltimetryCould Your Accounts Be Frozen?Allegiance GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Gold Grab of the CenturyColonial MetalsForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsREAD THIS – If You Missed Out On The AI BoomBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Physiomics Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
